Evidence map›Paper›PMID 27957319›Full record

ArticleMolecular autism2016

Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.

Maria Fiorentino, Anna Sapone, Stefania Senger, Stephanie S Camhi, Sarah M Kadzielski, Timothy M Buie, Deanna L Kelly, Nicola Cascella, Alessio Fasano

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Molecular autism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 249 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
249citing papers in PubMed, 6 pooled it
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05967871 phase1recruitingnot on this mapstarted 2024, after this paper: background citation

Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth

TypeinterventionalSponsorMcMaster Children's HospitalRan2024 to 2026Enrolled20ConditionsSmall Intestinal Bacterial OvergrowthArmsFecal Microbiota Transplant
NCT07450443 phase2 / phase3recruitingnot on this mapstarted 2023, after this paper: background citation

Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders: Evaluation of Efficacy of Postbiotic-based Nutraceutical Treatment

TypeinterventionalSponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaRan2023 to 2027Enrolled90ConditionsAutism, Autism Disorder, Autism Spectrum Disorder (ASD)ArmsPostbiotiX Comfort®, Control
3 · Its place in the literature

Who cites it

249 citing papers in PubMed, 6 syntheses or guidelines pooled it, 466 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. International journal of molecular sciences · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. A Developmental Neuroimmune Cascade Model of Autism Spectrum Disorder.International journal of molecular sciences · 2026
    Review
  20. Article

189 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Maria FiorentinoMucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, MA USA ; Department of Pediatrics, Harvard Medical School, Boston, MA USA.ORCID 0000-0001-5318-7313
Anna SaponeMucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, MA USA ; Department of Medicine, Celiac Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA USA.
Stefania SengerMucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, MA USA ; Department of Pediatrics, Harvard Medical School, Boston, MA USA.
Stephanie S CamhiMucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, MA USA ; Center for Celiac Research and Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital for Children, Boston, MA USA.
Sarah M KadzielskiDepartment of Pediatrics, Harvard Medical School, Boston, MA USA.
Timothy M BuieDepartment of Pediatrics, Harvard Medical School, Boston, MA USA.
Deanna L KellyMaryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD USA.
Nicola CascellaNeuropsychiatry Program, Sheppard Pratt Health System, Baltimore, MD USA.
Alessio FasanoMucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Boston, MA USA ; Center for Celiac Research and Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital for Children, Boston, MA USA ; Department of Pediatrics, Harvard Medical School, Boston, MA USA.
Boston Children's Hospital · USHarvard University · USBeth Israel Deaconess Medical Center · USMassachusetts General Hospital · USSheppard Pratt Health System · USUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutism spectrum disorders (ASD) are complex conditions whose pathogenesis may be attributed to gene-environment interactions. There are no definitive mechanisms explaining how environmental triggers can lead to ASD although the involvement of inflammation and immunity has been suggested. Inappropriate antigen trafficking through an impaired intestinal barrier, followed by passage of these antigens or immune-activated complexes through a permissive blood-brain barrier (BBB), can be part of the chain of events leading to these disorders. Our goal was to investigate whether an altered BBB and gut permeability is part of the pathophysiology of ASD.

methods

resultsClaudin (

conclusionsIn the ASD brain, there is an altered expression of genes associated with BBB integrity coupled with increased neuroinflammation and possibly impaired gut barrier integrity. While these findings seem to be specific for ASD, the possibility of more distinct SCZ subgroups should be explored with additional studies.

Indexed as

AdolescentAdultAutism Spectrum DisorderBiopsyBlood-Brain BarrierCalcium-Binding ProteinsCase-Control StudiesCerebellumCerebral CortexChildChild, PreschoolClaudin-3Claudin-5ClaudinsDNA-Binding ProteinsDuodenumAIF1 protein, humanCalcium-Binding ProteinsClaudin-3Claudin-5ClaudinsCLDN12 protein, humanCLDN3 protein, humanCLDN5 protein, humanDNA-Binding ProteinsIL1B protein, humanInterleukin-1betaInterleukin-8MARVELD2 protein, humanMARVEL Domain Containing 2 ProteinMatrix Metalloproteinase 9Microfilament ProteinsMMP9 protein, humanAutism spectrum disordersBlood–brain barrierDuodenal biopsiesGut–brain axisGut permeabilityNeuroinflammationPostmortem brainSchizophrenia

Identifiers

PMID27957319
PMCPMC5129651
OpenAlexW2559475643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.